Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis

Published:2022-03 Issue: Volume:104 Page:102354
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Tan Aaron C.,Tan Sze Huey,Zhou Siqin,Peters Solange,Curigliano Giuseppe,Tan Daniel S.W.

Funder

International Association for the Study of Lung Cancer

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference76 articles.

1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

2. Clinician perspectives on current issues in lung cancer drug development;Waqar;J Thorac Oncol,2016

3. Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer;Wolf;N Engl J Med,2020

4. Tepotinib in non-small-cell lung cancer with MET Exon 14 skipping mutations;Paik;N Engl J Med,2020

5. Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer;Drilon;N Engl J Med,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frankincense essential oil nanoemulsion specifically induces lung cancer apoptosis and inhibits survival pathways;Cancer Nanotechnology;2022-07-11

2. Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo;Journal of Translational Medicine;2022-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP